Ratings by BMO Capital (Malcolm Hoffman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2026 | LB Pharmaceuticals Inc | LBRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2026 | MapLight Therapeutics | MPLT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/27/2026 | MapLight Therapeutics | MPLT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2026 | Axsome Therapeutics | AXSM | New Coverage | Outperform (N/A) |
230.00 (202.83) |
-11.81% | Details | |
| 7/20/2026 | LB Pharmaceuticals Inc | LBRX | New Coverage | Outperform (N/A) |
31.41 (47.10) |
49.95% | Details | |
| 7/20/2026 | MapLight Therapeutics | MPLT | New Coverage | Outperform (N/A) |
37.87 (13.31) |
-64.85% | Details |
